Evaluation of HE4, CA-125, risk of ovarian malignancy algorithm [ROMA] and risk of malignancy index [RMI] in the preoperative assessment of patients with adnexal mass

Khawla, Al Musalhi; Manal, Al Kindi; Faiza, Al Aisary; Fatma, Ramadhan; Thuraya, Al Rawahi; Khalsa, Al Hatali; Waad Allah, Mula Abed

Khawla, Al Musalhi; Manal, Al Kindi; Faiza, Al Aisary; Fatma, Ramadhan; Thuraya, Al Rawahi; Khalsa, Al Hatali; Waad Allah, Mula Abed.

Oman Medical Journal. 2016; 31 (5): 336-344

in English | IMEMR | ID: emr-182054

ABSTRACT

ABSTRACT

Objectives:

To evaluate the validity and compare the performance of cancer antigen-125 [CA-125], human epididymis protein 4 [HE4], the risk of malignancy index [RMI], and the risk of ovarian malignancy algorithm [ROMA] in the diagnosis of ovarian cancer in patients with ovarian lesions discovered during their preoperative work-up investigations

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Practice guideline Language: English Journal: Oman Med. J. Year: 2016

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Practice guideline Language: English Journal: Oman Med. J. Year: 2016